Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
PHASE4
A multicenter, randomized, stratified, open-label, phase IV trial among HIV...
Status
Active Not Recruiting
Location
The Byramjee Jeejeebhoy Medical Centre (BJGMC-JHU) CRS
A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
PHASE3
The aim of this study is to assess the long-term safety of C1-esterase inhi...
Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)
PHASE1
Single-arm, single-center, Phase I/II clinical trial, in four groups. Indiv...
Status
Completed
Location
The Aurum Institute: Tembisa Clinical Research Centre